Co-occurrence of RUNX1 and ASXL1 Mutations Underlie Poor Response and Outcome for MDS Patients Treated with HMAs.
PubMed（2019）
Key words
Mutations,response,overall survival,myelodysplastic syndrome,hypomethylating agents
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined